- Anti-cancer drug identified by UCLA researchers shows promise treating high-risk COVID-19 patients
Researchers from UCLA are part of a collaboration of scientists from several universities studying the potential that the anti-cancer drug berzosertib could be effective in treating or preventing SARS-CoV-2, the virus that causes COVID-19.
December 01, 2021 9:00 AMdetail
- Joseph Shirk receives grant to study how virtual 3D tumor map can improve bladder cancer surgery
Dr. Joseph D. Shirk has been awarded a 2022 grant for $75,000 from the Margaret E. Early Medical Research Trust.
November 29, 2021 9:00 AMdetail
- UCLA research shows why immune checkpoint blockade impedes but does not stop glioblastoma progression
Like locking the door but opening windows, an immune checkpoint therapy temporarily slows glioblastoma (GBM) progression but fails to establish an effective anti-tumor microenvironment, according to studies led by a UCLA research team.
November 26, 2021 9:00 AMdetail
- New imaging technology developed by UCLA research team may reduce need for skin biopsies
Instead of surgically removing a sample of skin, sending it to a lab and waiting several days for results, your dermatologist takes pictures of a suspicious-looking lesion and quickly produces a detailed, microscopic image of the skin.
November 18, 2021 12:00 PMdetail
- Low-dose lung cancer screenings can reduce death by at least 20%, but usage is low
In this UCLA Health Connect blog, learn how annual screenings improve chances of catching disease early and new guidelines expand opportunities.
November 17, 2021 9:00 AMdetail
- UCLA scientists make strides toward an ‘off-the-shelf’ immune cell therapy for cancer
A new study by UCLA researchers report a critical step forward in the development of an “off-the-shelf” cancer immunotherapy using rare but powerful immune cells that could potentially be used to treat a wide range of patients with various cancers.
November 16, 2021 9:00 AMdetail
- Lung cancer: Ending stigma and improving treatment
Drew Moghanaki, MD, MPH, is on a mission to dismantle three major stereotypes about lung cancer: that it’s a smoker’s disease, that it isn’t curable and that surgery offers the only chance for survival.
November 02, 2021 9:00 AMdetail
- ASTRO: Optimizing preoperative radiation therapy in sarcoma
n a phase 2 single-institution study, UCLA Jonsson Comprehensive Cancer Center researchers found that dose-equivalent preoperative radiation therapy for extremity/trunk soft tissue sarcoma delivered in five days rather than over the conventional five weeks produced similar benefits and treatment side effects.
October 29, 2021 9:00 AMdetail
- ASTRO: Identifying unique genetic variants to overcome cancer treatment barriers
Dr. Robert Chin will describe recent research on personalized treatment for HPV-associated oropharyngeal cancer during a panel discussion on radiation and cancer biology at ASTRO, the annual meeting of the American Society for Radiation Oncology.
October 27, 2021 9:35 AMdetail
- ASTRO: International meta-analysis quantifies impact of three prostate cancer therapy intensification strategies
An individual patient data (IPD) meta-analysis of randomized, controlled clinical trials provides strong evidence for the addition of androgen deprivation therapy (ADT) to definitive radiotherapy (RT) for the treatment of prostate cancer, with the projection that adding ADT to the treatment of 10-15 men would prevent the development of distant metastasis in one man.
October 27, 2021 6:00 AMdetail
- Fighting cancer with the right mental health support
A bilateral mastectomy. Postponement of a 400-guest wedding. Disruption to a marketing career. The unknown of how treatment would affect fertility.
October 21, 2021 9:00 AMdetail
- Biomarkers may predict response patterns to immunotherapy before surgery in head and neck cancer
A new UCLA-led study revealed molecular biomarkers in the blood and tumors of patients with oral-cavity cancer could indicate how likely someone is to respond or not to immunotherapy before surgery to remove the tumor.
October 19, 2021 8:00 AMdetail
- Pioneering science at UCLA Health has changed breast cancer treatment worldwide
Long before Dennis Slamon, MD, PhD, was universally recognized for scientific discoveries that changed the trajectory of breast cancer and improved health outcomes for countless people across the globe, he just wanted to look at cancer differently.
October 14, 2021 9:00 AMdetail
- UCLA Health helps lead new initiative to improve colorectal cancer screening rates nationwide
UCLA Health has been named a key partner and major grant recipient in an innovative national initiative launched by Stand Up To Cancer® (SU2C), Exact Sciences and Providence Saint John’s Health Center, aimed at addressing healthcare disparities in colorectal cancer care and prevention.
October 13, 2021 9:00 AMdetail
- Moving away from toxic treatments for breast cancer
A UCLA oncologist’s new paper argues against the routine use of anthracycline chemotherapy drugs to treat breast cancer.
October 12, 2021 9:00 AMdetail
- UCLA researchers present on latest advancements at American Society for Radiation Oncology annual meeting
– Physicians and researchers from the UCLA Jonsson Comprehensive Cancer Center will highlight a variety of breakthrough research and innovative studies addressing a variety of challenges in radiation oncology at the annual American Society for Radiation Oncology (ASTRO) meeting, which takes place October 24 to 27.
October 06, 2021 8:30 AMdetail
- Alice Soragni awarded $2.5 million to develop lab-grown mini tumors for rare tumors
Dr. Alice Soragni has received a $2.5 million grant from the National Cancer Institute to develop lab-grown mini tumors that can help identify treatments for rare types of neuroendocrine cancer.
September 27, 2021 12:00 PMdetail
- Study finds people with blood cancer need more protection against COVID-19, even if vaccinated
New data suggests it’s the life-saving cancer treatment that increases the risk.
September 20, 2021 3:00 PMdetail
- ESMO: New drug shows promise in treating early-stage breast cancer
Early results from a UCLA-led clinical trial found treating women with estrogen receptor (ER)-positive and human epidermal growth factor receptor-2 (HER2)-negative early breast cancers with a novel type of anti-hormonal therapy, called an oral selective estrogen receptor degrader (SERD), led to clinically meaningful reductions in tumor activity prior to surgery.
September 20, 2021 8:30 AMdetail
- ESMO: HER2-targeting antibody-drug improves progression-free survival for women with deadly form of advanced breast cancer
A UCLA study has found that treating women with HER2 positive metastatic breast cancer with a HER2-targeting antibody-drug significantly prolongs the length of time the disease is controlled and cancer growth is halted.
September 18, 2021 9:30 AMdetail